Zobrazeno 1 - 10
of 31
pro vyhledávání: '"HIDEO UEKI"'
Autor:
Jingkai, Sun, Wenfeng, Lin, Chaoming, Li, Hideo, Ueki, Ruizhi, Xue, Takuya, Sadahira, Hao, Hu, Koichiro, Wada, Na, Li, Chunxiao, Liu, Motoo, Araki, Abai, Xu, Peng, Huang
Publikováno v:
Am J Cancer Res
Posaconazole (POS) is a novel antifungal agent, which has been repurposed as an anti-tumor drug for its potential inhibition of Hedgehog signaling pathway. Hedgehog pathway is reported to be abnormally activated in embryonal rhabdomyosarcoma (ERMS),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6027654a873fce456d1d5af0c755a08c
https://ousar.lib.okayama-u.ac.jp/62824
https://ousar.lib.okayama-u.ac.jp/62824
Autor:
Koichi Takeuchi, Masachika Fujiyoshi, Koichiro Wada, Yumi Kotera, Hideo Ueki, Noritaka Ariyoshi, Yasutomo Nasu, Shogo Watari, Jun Matsumoto, Toshihiro Koyama
Publikováno v:
Anticancer Research. 41:2511-2521
Background/Aim: This study aimed to elucidate the detailed characteristics of CYP3A5 expression and the association between CYP3A5 expression and clinical outcomes in patients with renal cell carcinoma (RCC). Patients and Methods: This study retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c924413472633e5f9cfe656cf74873fa
https://doi.org/10.21873/anticanres.15029
https://doi.org/10.21873/anticanres.15029
Autor:
Yasutomo Nasu, Kazuhiko Ochiai, Toyohiko Watanabe, Takuya Sadahira, Takehiro Iwata, Hideo Ueki, Motoo Araki, Peng Haung, Masami Watanabe, Takanori Sasaki
Publikováno v:
Exp Ther Med
REIC/Dkk-3 is a tumor suppressor, and its expression is significantly downregulated in a variety of human cancer types. A previous study performed yeast two-hybrid screening and identified the small glutamine-rich tetratricopeptide repeat-containing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec22b49ff624852eec8145f7f92da165
https://europepmc.org/articles/PMC7388570/
https://europepmc.org/articles/PMC7388570/
Autor:
Toshinori Omi, Masaki Michishita, Eri Onozawa, Saori Shono, Masami Watanabe, Hitomi Oda, Kazuhiko Ochiai, S. Sugihara, Hideo Ueki, Daigo Azakami, S. Nakazawa, L. Shun-Ai, Yuiko Kato, Makoto Bonkobara, Toshinori Sako
Publikováno v:
Veterinary and Comparative Oncology. 15:1181-1186
Reduced expression in immortalized cells (REIC/Dkk-3), a member of the human Dickkopf (Dkk) family, is a growth suppressor in human and canine mammary tumours. Mammary gland tumours are common neoplasms with high malignancy in female cats. The purpos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b18c12bf8a5b7b2271e63fbcfe0d8408
https://doi.org/10.1111/vco.12254
https://doi.org/10.1111/vco.12254
Autor:
Naijin, Xu, Xiezhao, Li, Masami, Watanabe, Hideo, Ueki, Hao, Hu, Na, Li, Motoo, Araki, Koichiro, Wada, Abai, Xu, Chunxiao, Liu, Yasutomo, Nasu, Peng, Huang
Publikováno v:
American journal of cancer research. 8(8)
Cancer stem cells (CSCs) that closely correlated with tumor growth, metastasis, provide a plausible explanation for chemoresistance and cancer relapse. CSCs are usually isolated and enriched from carcinoma cells, which is inconvenient, low-efficient,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a74c5ff48a21f81ecf1d1412be18113
https://pubmed.ncbi.nlm.nih.gov/30210930
https://pubmed.ncbi.nlm.nih.gov/30210930
Autor:
Naoya Kobayashi, Naruo Nikoh, A. M. J. Shapiro, Takako Tsugata, Chika Miyagi-Shiohira, Issei Saitoh, Tatsuya Kin, Yoshiki Nakashima, Hirofumi Noguchi, Hideo Ueki, Masami Watanabe, Yasufumi Noguchi
Publikováno v:
Cell Medicine
The low efficiency of in vitro differentiation of human embryonic stem cells (hESCs) or human-induced pluripotent stem cells (iPSCs) into insulin-producing cells is a crucial hurdle for the clinical implementation of human pluripotent stem cells (PSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df12877b05cb5ffa0d0160840a642f51
http://europepmc.org/articles/PMC6172987
http://europepmc.org/articles/PMC6172987
Autor:
Hiromi Kumon, Masami Watanabe, Masaki Michishita, Oumaporn Rungsuriyawiboon, Toshinori Omi, Yasutomo Nasu, Yuiko Kato, Hideo Ueki, Kazuhiko Ochiai, Masami Morimatsu, Yuichi Ariyoshi, Toshina Ishiguro-Oonuma, Chihiro Udagawa, Daigo Azakami
Publikováno v:
Oncotarget
ResearcherID
ResearcherID
// Kazuhiko Ochiai 1,* , Masami Morimatsu 2,* , Yuiko Kato 1 , Toshina Ishiguro-Oonuma 3 , Chihiro Udagawa 1 , Oumaporn Rungsuriyawiboon 4 , Daigo Azakami 1 , Masaki Michishita 5 , Yuichi Ariyoshi 6 , Hideo Ueki 6 , Yasutomo Nasu 6 , Hiromi Kumon 6 ,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa0a2c19ba8581624a56b76ae7c26db5
https://doi.org/10.18632/oncotarget.6488
https://doi.org/10.18632/oncotarget.6488
Autor:
Hideo Ueki, Tatsuya Kin, Hirofumi Noguchi, Masami Watanabe, A. M. J. Shapiro, Issei Saitoh, Yasufumi Noguchi, Naruo Nikoh, Takako Tsugata
Publikováno v:
Cell Medicine. 7:83-93
The low efficiency of in vitro differentiation of human embryonic stem cells (ESCs) or human induced pluripotent stem cells (iPSCs) into insulin-producing cells thus creates a crucial hurdle for the clinical implementation of human pluripotent stem c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb419c12a98fbf9634d416940623eda0
https://doi.org/10.3727/215517914x685178
https://doi.org/10.3727/215517914x685178
Autor:
Yasutomo Nasu, Akiko Sakai, Peng Huang, Kenji Shimizu, Chao Ma, Kai Guo, Haruki Kaku, Jie Chen, Masami Watanabe, Hideo Ueki, Hiromi Kumon, Chunxiao Liu
Publikováno v:
Oncology Letters
The Wnt signaling pathway plays a crucial role in human cancer development, and axis inhibition protein 2 (Axin2) is a master scaffold protein involved in Wnt signaling. Axin2 negatively regulates Wnt signaling and acts as a tumor suppressor protein.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7718f28d30c9aa7e8597dc49d9467e6
https://doi.org/10.3892/ol.2014.2177
https://doi.org/10.3892/ol.2014.2177
Autor:
Ryuta Tanimoto, Yuichi Ariyoshi, Shun Ai Li, Kazuhiko Ochiai, Hiromi Kumon, Masami Watanabe, Hideo Ueki, Haruki Kaku, Yasutomo Nasu, Nam Ho Huh, Junichiro Futami, Shin Ebara, Peng Huang, Rie Kinoshita, Masakiyo Sakaguchi
Publikováno v:
Oncology Reports
Gene expression systems with various promoters, including the cytomegalovirus (CMV) promoter, have been developed to increase the gene expression in a variety of normal and cancer cells. In particular, in the clinical trials of cancer gene therapy, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0edd26cfdfd292ea0447c6482d6517f2
https://doi.org/10.3892/or.2013.2958
https://doi.org/10.3892/or.2013.2958